NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Daiichi Sankyo

Daiichi Sankyo

Overview

Daiichi Sankyo is a global pharmaceutical company headquartered in Japan, focused on the research, development, and commercialization of innovative medicines, with a primary emphasis on oncology. The company also engages in strategic investment activities, including corporate venture investments, acquisitions of biotechnology firms, and acting as a Limited Partner (LP) in external healthcare venture funds to enhance its research and development pipeline and access novel technologies.

Portfolio Companies

1

Investments

Daiichi Sankyo investments
CompanyDateStageLead
NovelliaAug 2023Corporate FundingCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.